Shilpa Medicare Share Price

Barcelona, Spain & Raichur, Karnataka, India Business Wire India

• Business Line
• 2 weeks 5 days ago

Conference Call with Shilpa Medicare Management and Analysts on Q4FY26 & Full Year Performance and Outlook. Listen to the full earnings transcript.

• Trendlyne
• 1 month ago

Pharmaceuticals company Shilpa Medicare announced Q4FY26 & FY26 results Standalone Financial Highlights: Revenue from Operations: Q4FY26: Rs 20,111 lakh, compared to Rs 16,686 lakh in Q3FY26 (QoQ increase of 20.53%) and Rs 12,621 lakh in Q4FY25 (YoY increase of 59.35%). FY26: Rs 59,703 lakh, compared to Rs 47,741 lakh in FY25 (YoY increase of 25.05%). Total Income: Q4FY26: Rs 20,800 lakh, compared to Rs 17,310 lakh in Q3FY26 (QoQ increase of 20.16%) and Rs 13,685 lakh in Q4FY25 (YoY increase of 52.00%). FY26: Rs 63,517 lakh, compared to Rs 54,708 lakh in FY25 (YoY increase of 16.10%). Net Profit After Tax: Q4FY26: Rs 7,096 lakh, compared to Rs 1,411 lakh in Q3FY26 (QoQ increase of 402.91%) and Rs (563) lakh in Q4FY25. FY26: Rs 13,297 lakh, compared to Rs 6,789 lakh in FY25 (YoY increase of 95.86%). Consolidated Financial Highlights: Revenue from Operations: Q4FY26: Rs 43,699 lakh, compared to Rs 41,028 lakh in Q3FY26 (QoQ increase of 13.07%) and Rs 33,082 lakh in Q4FY25 (YoY decrease of 4.13%). FY26: Rs 153,887 lakh, compared to Rs 128,643 lakh in FY25 (YoY increase of 13.30%). Total Income: Q4FY26: Rs 43,866 lakh, compared to Rs 41,054 lakh in Q3FY26 (QoQ increase of 12.29%) and Rs 33,845 lakh in Q4FY25 (YoY decrease of 3.64%). FY26: Rs 154,871 lakh, compared to Rs 130,976 lakh in FY25 (YoY increase of 13.47%). Net Profit After Tax: Q4FY26: Rs 10,779 lakh, compared to Rs 4,458 lakh in Q3FY26 (QoQ increase of 39.37%) and Rs 1,451 lakh in Q4FY25 (YoY increase of 61.03%). FY26: Rs 24,333 lakh, compared to Rs 7,829 lakh in FY25 (YoY increase of 47.52%). Business Highlights: Dividend: The Board recommended a final dividend of Re. 0.60 per equity share (60% on the face value of Re. 1/- each) for the financial year 2025-26, subject to approval at the ensuing Annual General Meeting. Registered Office Shifting: The Board approved the shifting of the registered office from Raichur, Karnataka, to the state of Maharashtra, subject to member approval via Postal Ballot. Strategic Investments: The Company and its wholly-owned subsidiaries (SPL, SBPL, Biocare) approved an equity investment of 28% in Neo Green Power Project Private Limited to meet captive power consumption requirements. Auditor Appointments: M/s. V.J. Talati & Co., Cost Accountants, appointed as Cost Auditors for FY27. M/s. Aneja Associates, appointed as Internal Auditors for FY27. Segment Information: The Company operates in the manufacturing of products of the same type/class and is considered to have a single reportable segment, "Pharmaceuticals." Labour Codes: In compliance with new Labour Codes, the Company recognized past service costs amounting to Rs 103.09 lakh (previous quarter) and Rs 96.81 lakh (current quarter) within employee benefit expenses. Result PDF

• Trendlyne
• 1 month ago